Feng Wang Selected Research

Feng Wang Research Topics

Disease

621	Neoplasms (Cancer) 10/2022 - 01/2002
120	Neoplasm Metastasis (Metastasis) 03/2022 - 03/2002
105	Inflammation (Inflammations) 10/2022 - 06/2008
87	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2007
86	Infections 07/2022 - 05/2002
69	Stomach Neoplasms (Stomach Cancer) 10/2022 - 03/2006
61	Carcinogenesis 01/2022 - 04/2010
57	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2002
54	Hypoxia (Hypoxemia) 06/2022 - 11/2004
50	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2002
46	Esophageal Squamous Cell Carcinoma 03/2022 - 01/2009
45	Lung Neoplasms (Lung Cancer) 05/2022 - 08/2002
43	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 12/2006
40	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2006
39	Fibrosis (Cirrhosis) 10/2022 - 02/2011
38	Carcinoma (Carcinomatosis) 12/2021 - 10/2003
37	Insulin Resistance 01/2022 - 04/2002
35	COVID-19 07/2022 - 01/2020
33	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 05/2007
32	Atherosclerosis 07/2022 - 01/2010
32	Glioma (Gliomas) 06/2022 - 07/2009
30	Type 2 Diabetes Mellitus (MODY) 05/2022 - 02/2003
28	Wounds and Injuries (Trauma) 01/2022 - 12/2002
28	Tuberculosis (Tuberculoses) 01/2022 - 04/2006
27	Lymphatic Metastasis 12/2021 - 08/2008
26	Stroke (Strokes) 01/2022 - 07/2004
26	Body Weight (Weight, Body) 10/2021 - 02/2011
25	Ischemic Stroke 12/2022 - 09/2004
25	Necrosis 06/2022 - 03/2002
25	Hypertension (High Blood Pressure) 06/2022 - 07/2004
24	Ischemia 05/2022 - 10/2002
24	Adenocarcinoma 01/2022 - 05/2009
23	Reperfusion Injury 05/2022 - 10/2002
23	Infarction (Infarctions) 05/2022 - 12/2006
22	Obesity 01/2022 - 04/2002
21	Brain Ischemia (Cerebral Ischemia) 01/2022 - 02/2011
18	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 03/2008
18	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2012
17	Colonic Neoplasms (Colon Cancer) 03/2022 - 05/2009
17	Pain (Aches) 01/2022 - 11/2008
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2012
17	Epilepsy (Aura) 12/2021 - 05/2010
17	Hepatitis B 12/2020 - 07/2003
16	Hemorrhage 01/2022 - 08/2013
16	Urinary Bladder Neoplasms (Bladder Cancer) 12/2021 - 01/2017
16	Hypertrophy 01/2021 - 05/2002
16	Pancreatitis 10/2020 - 01/2008
15	Squamous Cell Carcinoma of Head and Neck 02/2022 - 06/2012
14	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 12/2005
14	Parkinson Disease (Parkinson's Disease) 06/2022 - 12/2008

Drug/Important Bio-Agent (IBA)

236	Proteins (Proteins, Gene)FDA Link 10/2022 - 05/2002
126	Biomarkers (Surrogate Marker)IBA 07/2022 - 07/2006
82	Pharmaceutical PreparationsIBA 06/2022 - 07/2003
73	Biological ProductsIBA 06/2022 - 07/2006
70	Messenger RNA (mRNA)IBA 01/2022 - 01/2002
62	MicroRNAs (MicroRNA)IBA 03/2022 - 09/2011
57	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 12/2002
54	Long Noncoding RNAIBA 02/2022 - 01/2014
53	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2006
52	CytokinesIBA 09/2022 - 05/2002
41	EnzymesIBA 05/2022 - 05/2005
38	AntigensIBA 04/2022 - 09/2011
33	Therapeutic UsesIBA 06/2022 - 07/2008
32	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 09/2006
32	Peptides (Polypeptides)IBA 04/2022 - 05/2005
29	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2002
28	Insulin (Novolin)FDA Link 05/2022 - 04/2002
28	LipidsIBA 10/2021 - 02/2006
28	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2002
27	LigandsIBA 04/2022 - 09/2003
27	Circular RNAIBA 01/2022 - 01/2018
22	Indicators and Reagents (Reagents)IBA 01/2022 - 02/2007
21	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2004
21	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021 - 05/2009
20	Phosphotransferases (Kinase)IBA 01/2022 - 05/2005
20	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2002
20	AntibodiesIBA 01/2022 - 01/2004
20	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2020 - 07/2004
19	Oxygen (Dioxygen)IBA 01/2022 - 07/2009
19	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2009
19	CateninsIBA 01/2019 - 08/2009
18	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 05/2011
18	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2012
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 01/2002
17	Immune Checkpoint InhibitorsIBA 03/2022 - 04/2017
16	gallium 68 PSMA-11IBA 10/2022 - 02/2017
16	LipopolysaccharidesIBA 07/2022 - 01/2014
16	Interleukin-6 (Interleukin 6)IBA 05/2022 - 11/2012
16	AlbuminsIBA 04/2022 - 09/2007
16	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 08/2009
16	salicylhydroxamic acid (SHAM)IBA 10/2021 - 10/2002
16	Cadherins (E-Cadherin)IBA 10/2019 - 01/2006
15	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2021 - 12/2007
14	AcidsIBA 07/2022 - 06/2008

Therapy/Procedure

259	Therapeutics 12/2022 - 01/2004
95	Drug Therapy (Chemotherapy) 06/2022 - 09/2003
34	Radiotherapy 10/2022 - 01/2012
28	Immunotherapy 01/2022 - 10/2014
20	Stents 10/2021 - 02/2006
16	Transplantation 01/2022 - 07/2004